Antikor invited to ‘Accessing US Capital In Life Sciences’, 1st December 2015

Antikor is attending this 'by invitation only' event in London on 1st December 2015, organsied by Sullivan & Cromwell LLP, London Stock Exchange, RBC Capital Markets and Clermont Partners.

Specialists will be on hand to address questions such as UK vs US listing venues and the different regulatory and legal challenges, the depth and breadth of the respective capital markets for life sciences, what types of profiles of companies are most attractive to US investors and how should non-US companies alter their IR and PR strategies to best appeal to US investors.